Back to Journals » Biologics: Targets and Therapy » Volume 3
Review
Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,413 | Dovepress* | 14,413+ | 2,591 | 17,004 | |
Totals | 14,413 | 2,591 | 17,004 | ||
*Since 17 June 2009 +Since July 2016 |
View citations on Google Scholar